Abstract
Introduction/BackgroundA high platelet-lymphocyte ratio (PLR) is a marker of systemic inflammation and, together with the neutrophil-lymphocyte ratio (NLR), is associated with poor outcomes in several cancers. We investigated the prognostic...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
